Advertisement

Endocrine

pp 1–6 | Cite as

Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects

  • Mahmoud Ali Kaykhaei
  • Mahdieh Khodadoost
  • Ali Reza Dashipour
  • Zahra Haidari
  • Azra karimkoshteh
  • Mahnaz SandoughiEmail author
Original Article
  • 3 Downloads

Abstract

Introduction

Vitamin D deficiency is a major health problem which affects about one billion people in the world. Although, vitamin D supplementation is recommended as standard treatment of vitamin D deficiency, there are controversies on dose response relationship. In this regard, the present study aimed to determine the impact of vitamin D3 supplement on raising of serum 25 hydroxyvitamin D[25(OH)D] in healthy subjects with varying degrees of vitamin D deficiency.

Materials and methods

In this clinical trial 114 subjects with varying degrees of vitamin D deficiency were entered and divided into three groups: serum levels of 25(OH) D less than 10 ng/ml, 10–20 ng/ml, and 20–30 ng/ml. All of the participants were given 50,000 units vitamin D3 per week for 8 weeks, thereafter, changes in serum levels of vitamin D and PTH were evaluated at week twelve. The results were analyzed using SPSS version 16 and P < 0.05 was considered to be significant.

Results

Of the 114 vitamin D deficient subjects, serum level of vitamin D was below 10 ng/ml in 22 persons (19.3%), 10–20 ng/ml in 52 persons (45.6%) and 20–30 ng/ml in 40 persons (35.1%). Following vitamin D prescription all people with varying degrees of vitamin D deficiency obtained a favorable serum level. The increase in vitamin D levels were 26.4, 18.5, and 8.3 ng/ml, in individuals with baseline vitamin D levels below 10 ng/ml, 10–20 ng/ml and 20–30 ng/ml, respectively. The changes in 25(OH) vitamin D in all three groups were significant (P < 0.05), nonetheless no significant alterations in serum levels of PTH were observed (P > 0.05).

Conclusion

Our results indicated an inverse relationship between baseline serum levels of 25(OH) D and its increment following treatment with vitamin D3. Therefore, the magnitude of increments in serum 25(OH) D is greater in subjects with lower baseline levels of 25(OH) D.

Keywords

Vitamin D deficiency Dose response relationship Treatment 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    R. Lin, J.H. White, The pleiotropic actions of vitamin D. Bioessays 26, 21–28 (2004)CrossRefGoogle Scholar
  2. 2.
    M.A. Kaykhaei, M. Hashemi, B. Narouie, A. Shikhzadeh, H. Rashidi, N. Moulaei, S. Ghavami, High prevalence of vitamin D deficiency in Zahedan, southeast Iran. Ann. Nutr. Metab. 58, 37–41 (2011)CrossRefGoogle Scholar
  3. 3.
    S.H. Masood, M.P. Iqbal, Prevalence of vitamin D deficiency in South Asia. Angiogenesis 1, 12 (2008)Google Scholar
  4. 4.
    M.F. Holick, Vitamin D deficiency. N. Engl. J. Med 357, 266–281 (2007)CrossRefGoogle Scholar
  5. 5.
    M.F. Holick, in Evolution and Function of Vitamin D. In: Reichrath J., Tilgen W., Friedrich M. (eds). Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. (Springer, Berlin, Heidelberg, 2003) pp. 3–28Google Scholar
  6. 6.
    J.S.R.B. Adams, S. Witzel, R.E. Reyes, A. Shieh, R. Chun et al. Regulation of the extrarenal CYP27B1-hydroxylase. J. Steroid Biochem. Biol. 144, 22–27 (2014)CrossRefGoogle Scholar
  7. 7.
    H.A.P. Harant, G.S. Reddy, E. Foglar, I.J.D. Lindley, 1 alpha,25-dihydroxyvitamin D-3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappa B-mediated interleukin-8 gene expression. Eur. J. Biochem. 250, 63–71 (1997)Google Scholar
  8. 8.
    J.R. Sabetta, P. DePetrillo, R.J. Cipriani, J. Smardin, L.A. Burns, M.L. Landry, Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 5, e11088 (2010)CrossRefGoogle Scholar
  9. 9.
    M. Juonala, A. Voipio, K. Pahkala, J.S. Viikari, V. Mikkilä, M. Kähönen, N. Hutri-Kähönen, A. Jula, D. Burgner, M.A. Sabin, Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. The. J. Clin. Endocrinol. Metab. 100, 1469–1476 (2015)CrossRefGoogle Scholar
  10. 10.
    B. Rhead, M. Bäärnhielm, M. Gianfrancesco, A. Mok, X. Shao, H. Quach, L. Shen, C. Schaefer, J. Link, A. Gyllenberg, Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol. Genet. 2, e97 (2016)CrossRefGoogle Scholar
  11. 11.
    C. Annweiler, Y. Rolland, A.M. Schott, H. Blain, B. Vellas, F.R. Herrmann, O. Beauchet, Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: a 7-year follow-up. J. Gerontol. Ser. A 67, 1205–1211 (2012)CrossRefGoogle Scholar
  12. 12.
    R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J.C. Kiefte-de-Jong, H. Khan, C.P. Baena, D. Prabhakaran, M.B. Hoshen, Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903 (2014)CrossRefGoogle Scholar
  13. 13.
    P. Bergman, A.-C. Norlin, S. Hansen, R.S. Rekha, B. Agerberth, L. Björkhem-Bergman, L. Ekström, J.D. Lindh, J. Andersson, Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2, e001663 (2012)CrossRefGoogle Scholar
  14. 14.
    A.-C. Norlin, S. Hansen, E. Wahren-Borgström, C. Granert, L. Björkhem-Bergman, P. Bergman, Vitamin D3 supplementation and antibiotic consumption–results from a prospective, observational study at an immune-deficiency unit in Sweden. PLoS ONE 11, e0163451 (2016)CrossRefGoogle Scholar
  15. 15.
    P. Pludowski, M.F. Holick, S. Pilz, C.L. Wagner, B.W. Hollis, W.B. Grant, Y. Shoenfeld, E. Lerchbaum, D.J. Llewellyn, K. Kienreich, Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun. Rev. 12, 976–989 (2013)CrossRefGoogle Scholar
  16. 16.
    J.-C. Souberbielle, J.-J. Body, J.M. Lappe, M. Plebani, Y. Shoenfeld, T.J. Wang, H.A. Bischoff-Ferrari, E. Cavalier, P.R. Ebeling, P. Fardellone, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev. 9, 709–715 (2010)CrossRefGoogle Scholar
  17. 17.
    J. Lappe, D. Travers-Gustafson, K. Davies, R. Recker, R. Heaney, Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial (American Journal of Clinical Nutrition (2007) 85,(1586–1591)). Am. J. Clin. Nutr. 87, 794 (2008)CrossRefGoogle Scholar
  18. 18.
    P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2, 76–89 (2014)CrossRefGoogle Scholar
  19. 19.
    E. Theodoratou, I. Tzoulaki, L. Zgaga, J.P. Ioannidis, Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035 (2014)CrossRefGoogle Scholar
  20. 20.
    R. Scragg, Emerging evidence of thresholds for beneficial effects from vitamin D supplementation. Nutrients 10, 561 (2018)CrossRefGoogle Scholar
  21. 21.
    S. Spedding, S. Vanlint, H. Morris, R. Scragg, Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 5, 5127–5139 (2013)CrossRefGoogle Scholar
  22. 22.
    R. Bouillon, Comparative analysis of nutritional guidelines for vitamin D. Nat. Rev. Endocrinol 13, 466–479 (2017)CrossRefGoogle Scholar
  23. 23.
    L.B.F. Cianferotti, H.A. Bischoff-Ferrari, O. Bruyere, C. Cooper, M. Cutolo, J.A. Kanis, J.M. Kaufman, J.Y. Reginster, R. Rizzoli, M.L. Brandi, Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Endocrine 56, 245–261 (2017)CrossRefGoogle Scholar
  24. 24.
    P. Płudowski, E. Karczmarewicz, M. Bayer, G. Carter, D. Chlebna-Sokół, J. Czech-Kowalska, R. Dębski, T. Decsi, A. Dobrzańska, E. Franek, Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe—recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol. Pol. 64, 319–327 (2013)CrossRefGoogle Scholar
  25. 25.
    M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011)CrossRefGoogle Scholar
  26. 26.
    A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011)CrossRefGoogle Scholar
  27. 27.
    A. Haq, S.J. Wimalawansa, P. Pludowski, F. Al Anouti, Clinical practice guidelines for vitamin D in the United Arab Emirates. J. Steroid Biochem. Mol. Biol. 175, 4–11 (2016)CrossRefGoogle Scholar
  28. 28.
    P. Byrne, R. Freaney, M. McKenna, Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes. Calcif. Tissue Int. 56, 518–520 (1995)CrossRefGoogle Scholar
  29. 29.
    V. Chel, M. Ooms, C. Popp‐Snijders, S. Pavel, A. Schothorst, C. Meulemans, P. Lips, Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J. Bone Miner. Res. 13, 1238–1242 (1998)CrossRefGoogle Scholar
  30. 30.
    M.A.J. Kyriakidou-Himonas, J.K. Yeh, Vitamin D supplementation in postmenopausal black women. J. Clin. Endocrinol. Metab. 84, 3988–3990 (1999)CrossRefGoogle Scholar
  31. 31.
    R.P. Heaney, K.M. Davies, T.C. Chen, M.F. Holick, M.J. Barger-Lux, Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003)CrossRefGoogle Scholar
  32. 32.
    J.C. Gallagher, A. Sai, T. Templin, L. Smith, Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann. Intern. Med. 156, 425–437 (2012)CrossRefGoogle Scholar
  33. 33.
    P. Autier, S. Gandini, P. Mullie, A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J. Clin. Endocrinol. Metab. 97, 2606–2613 (2012)CrossRefGoogle Scholar
  34. 34.
    A. Drincic, E. Fuller, R.P. Heaney, L.A. Armas, 25-Hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults. J. Clin. Endocrinol. Metab. 98, 4845–4851 (2013)CrossRefGoogle Scholar
  35. 35.
    H.M. Trang, D. Cole, L.A. Rubin, A. Pierratos, S. Siu, R. Vieth, Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr. 68, 854–858 (1998)CrossRefGoogle Scholar
  36. 36.
    J.M. Quesada-Gomez, Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos. Int. 29, 1697–1711 (2018)CrossRefGoogle Scholar
  37. 37.
    A. Shieh, C. Ma, R.F. Chun, J. Wittwer-Schegg, L. Swinkels, T. Huijs, J. Wang, I. Donangelo, M. Hewison, J.S. Adams, Associations between change in total and free 25-hydroxyvitamin D with 24, 25-dihydroxyvitamin D and parathyroid hormone. J. Clin. Endocrinol. Metab. 8, e1187349 (2018)Google Scholar
  38. 38.
    H. Ketha, T.D. Thacher, S.S. Oberhelman, P.R. Fischer, R.J. Singh, R. Kumar, Comparison of the effect of daily versus bolus dose maternal vitamin D3 supplementation on the 24, 25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio. Bone 110, 321–325 (2018)CrossRefGoogle Scholar
  39. 39.
    T.J. Wang, F. Zhang, J.B. Richards, B. Kestenbaum, J.B. Van Meurs, D. Berry, D.P. Kiel, E.A. Streeten, C. Ohlsson, D.L. Koller, Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180–188 (2010)CrossRefGoogle Scholar
  40. 40.
    A. Bakhshipour, M.A. Kaykhaei, N. Moulaei, M.A. Mashhadi, Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. Arab J. Gastroenterol. 14, 113–115 (2013)CrossRefGoogle Scholar
  41. 41.
    J.P. Ekwaru, J.D. Zwicker, M.F. Holick, E. Giovannucci, P.J. Veugelers, The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE 9, e111265 (2014)CrossRefGoogle Scholar
  42. 42.
    S.M. Pietras, B.K. Obayan, M.H. Cai, M.F. Holick, Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch. Intern. Med. 169, 1806–1818 (2009)CrossRefGoogle Scholar
  43. 43.
    R. Vieth, P.-C.R. Chan, G.D. MacFarlane, Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level–. Am. J. Clin. Nutr. 73, 288–294 (2001)CrossRefGoogle Scholar
  44. 44.
    R.A. Durazo-Arvizu, B. Dawson-Hughes, H. Kramer, G. Cao, J. Merkel, P.M. Coates, C.T. Sempos, The reverse J-shaped association between serum total 25-hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization. Am. J. Epidemiol. 185, 720–726 (2017)CrossRefGoogle Scholar
  45. 45.
    P.G.-J.A. Caillet, M. Viprey, A.M. Schott, Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study. Sci. Rep. 7, 10361 2017)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Mahmoud Ali Kaykhaei
    • 1
    • 2
  • Mahdieh Khodadoost
    • 1
  • Ali Reza Dashipour
    • 3
  • Zahra Haidari
    • 1
  • Azra karimkoshteh
    • 1
  • Mahnaz Sandoughi
    • 1
    • 4
    Email author
  1. 1.Department of Internal Medicine, Ali-EbneAbitaleb HospitalZahedan University of Medical SciencesZahedanIran
  2. 2.Genetics of non-Communicable Disease Research CenterZahedan University of Medical SciencesZahedanIran
  3. 3.Department of Food Sciences and NutritionZahedan University of Medical SciencesZahedanIran
  4. 4.Clinical Immunology Research CenterZahedan University of Medical SciencesZahedanIran

Personalised recommendations